National Healthcare Corp
NHC NYSE· Services-Skilled Nursing Care Facilities
Last close · Oct 27, 2026
$211.81
KIRA · Stoqly’s AI analyst, in plain words
- National Healthcare Corp had $1.5B of revenue in fiscal 2025, up 16.1% on the year before. Over five years, revenue changed +8.1% a year on average.
- Its operating margin was 8.5%, up 1.6 pts: of every 100 in sales, about 8 is left after running the business.
- National Healthcare Corp made $120M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 9.8% a year.
- Free cash flow was $149M in fiscal 2025, 9.8% of revenue.
- National Healthcare Corp returned $53.4M to shareholders in fiscal 2025, 36% of free cash flow. The diluted share count rose 0.3%.
- National Healthcare Corp has $52.8M more cash than debt.
Market cap
$3.4B
P/E
23.8x
Revenue
$1.5B
Net income
$120M
Free cash flow
$149M
Operating margin
8.5%
National Healthcare Corp in 30 seconds · fiscal 2025
Are sales growing?
+16.1%
Yes. Sales grew 16.1% last year.
Does it make a profit?
7.9%
A little. It keeps 7.9% of every sale as profit.
Does profit turn into cash?
9.8%
Partly. 9.8% of sales ends up as free cash.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
7 / 8
Solid. It passes 7 of 8 health tests.
How is the share priced?
23.8x
One share costs 23.8 times its yearly profit per share.
What National Healthcare Corp does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Legal name
- NATIONAL HEALTHCARE CORP
- CIK
- 0001047335
National Healthcare Corp · NHC
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $1.1B | $1.1B | $1.1B | $1.3B | $1.5B |
| Revenue growth | 4.5% | 1.1% | 5.1% | 14.5% | 16.1% |
| Operating margin | 4.7% | 2.9% | 5.0% | 6.9% | 8.5% |
| Net income | $139M | $22.4M | $66.8M | $102M | $120M |
| Net margin | 12.9% | 2.1% | 5.9% | 7.8% | 7.9% |
| Diluted EPS | $8.99 | $1.45 | $4.34 | $6.53 | $7.67 |
| Cash | |||||
| Cash from operations | $62.4M | $8.7M | $111M | $107M | $185M |
| Capital expenditure | $39.4M | $30.2M | $27.9M | $27.6M | $36.4M |
| Free cash flow | $23.0M | −$21.5M | $83.3M | $79.7M | $149M |
| FCF margin | 2.1% | −2.0% | 7.3% | 6.1% | 9.8% |
| Dividends paid | $32.0M | $34.6M | $35.6M | $37.0M | $38.7M |
| Share buybacks | $0.8M | $9.9M | $2.5M | $13.5M | $14.7M |
| Share count change | 0.3% | 0.2% | −0.5% | 1.4% | 0.3% |
| Debt and strength | |||||
| Cash and short-term investments | $108M | $58.7M | $107M | $76.1M | $92.8M |
| Debt incl. finance leases | — | — | $0.9M | $137M | $40.0M |
| Shareholders' equity | $903M | $874M | $909M | $980M | $1.1B |
| Net debt / EBITDA | — | — | −1.1x | 0.5x | −0.3x |
| Current ratio | 1.6x | 1.8x | 1.9x | 1.8x | 1.8x |
| Interest coverage | 60.3x | 56.7x | 177.3x | 21.7x | 20.1x |
| Returns and quality | |||||
| Return on capital | — | — | 5.3% | 6.5% | 9.5% |
| Return on equity | 16.3% | 2.5% | 7.5% | 10.8% | 11.7% |
| Return on tangible equity | 19.0% | 3.2% | 9.1% | 12.9% | 13.7% |
| Piotroski F-score | 4 | 4 | 7 | 4 | 7 |
| Altman Z'' | 4.5 | 5.0 | 5.3 | 4.7 | 5.7 |
Insiders bought, 12 months
$0.2M
1 insider
Insiders sold, 12 months
$11.2M
9 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
National Healthcare Corp · NHC
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $211.81 a share, the company is worth $3.4B: 23.8 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001047335). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.